Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-21 4:05 pm Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Venrock Healthcare Capital Partners II L.P. | 3,668,334 9.990% | 3,668,334 (New Position) | Filing History |
| 2022-02-14 4:21 pm Purchase | 2021-12-31 | 13G | Sierra Oncology, Inc. SRRA | Venrock Healthcare Capital Partners II L.P. | 984,746 6.100% | 979,565 (+18907.15%) | Filing History |
| 2022-02-14 4:20 pm Sale | 2021-12-31 | 13G | Altimmune, Inc. ALT | Venrock Healthcare Capital Partners II L.P. | 1,760,870 4.200% | -1,862,094 (-51.40%) | Filing History |
| 2022-02-14 4:20 pm Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II L.P. | 534,910 8.000% | 60,235 (+12.69%) | Filing History |
| 2022-02-14 4:19 pm Purchase | 2021-11-17 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II L.P. | 3,494,851 6.300% | 3,494,851 (New Position) | Filing History |
| 2022-02-14 4:19 pm Purchase | 2021-03-26 | 13G | Relmada Therapeutics, Inc. RLMD | Venrock Healthcare Capital Partners II L.P. | 2,270,072 8.200% | 1,601,632 (+239.61%) | Filing History |
| 2022-02-14 4:18 pm Purchase | 2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Venrock Healthcare Capital Partners II L.P. | 2,880,096 7.800% | 291,155 (+11.25%) | Filing History |
| 2022-02-14 4:17 pm Sale | 2021-12-31 | 13G | aTyr Pharma, Inc. ATYR | Venrock Healthcare Capital Partners II L.P. | 1,565,000 5.600% | -250,000 (-13.77%) | Filing History |
| 2022-02-14 4:15 pm Sale | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Venrock Healthcare Capital Partners II L.P. | 250,000 0.500% | -3,177,461 (-92.71%) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | Venrock Healthcare Capital Partners II L.P. | 1,000,000 2.700% | -691,623 (-40.89%) | Filing History |
| 2022-02-14 4:14 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Venrock Healthcare Capital Partners II L.P. | 4,302,126 9.990% | 4,302,126 (New Position) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-08-26 | 13G | Aadi Bioscience, Inc. AADI | Venrock Healthcare Capital Partners II L.P. | 1,529,402 7.300% | 1,529,402 (New Position) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-01-19 | 13G | Aclaris Therapeutics, Inc. ACRS | Venrock Healthcare Capital Partners II L.P. | 4,563,962 7.500% | 4,563,962 (New Position) | Filing History |
| 2021-11-10 4:05 pm Purchase | 2021-10-31 | 13G | LianBio LIANY | Venrock Healthcare Capital Partners II L.P. | 5,378,341 5.100% | 5,378,341 (New Position) | Filing History |
| 2021-09-30 4:05 pm Purchase | 2021-09-20 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Venrock Healthcare Capital Partners II L.P. | 3,427,461 8.100% | 3,427,461 (New Position) | Filing History |
| 2021-09-27 5:14 pm Purchase | 2021-09-16 | 13G | aTyr Pharma, Inc. ATYR | Venrock Healthcare Capital Partners II L.P. | 1,815,000 6.700% | 1,815,000 (New Position) | Filing History |
| 2021-06-07 4:30 pm Purchase | 2021-05-26 | 13G | Provention Bio, Inc. PRVB | Venrock Healthcare Capital Partners II L.P. | 3,843,796 6.100% | 3,843,796 (New Position) | Filing History |
| 2021-04-15 4:09 pm Purchase | 2021-03-23 | 13G | Instil Bio, Inc. TIL | Venrock Healthcare Capital Partners II L.P. | 343,254 5.400% | 343,254 (New Position) | Filing History |
| 2021-03-01 4:07 pm Sale | 2021-02-25 | 13G | Altimmune, Inc. ALT | Venrock Healthcare Capital Partners II L.P. | 3,622,964 9.990% | -877,036 (-19.49%) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II L.P. | 474,675 9.990% | 474,675 (New Position) | Filing History |